Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B

Ahsan, 2005, Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells, J. Pharmacol. Exp. Ther., 315, 1028, 10.1124/jpet.105.092213 Arnon, 2001, Botulinum toxin as a biological weapon: medical and public health management, JAMA, 285, 1059, 10.1001/jama.285.8.1059 Bigalke, 2005, Medical aspects of toxin weapons, Toxicology, 214, 210, 10.1016/j.tox.2005.06.015 Chen, 1998, Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species, Infect. Immun., 66, 2420, 10.1128/IAI.66.6.2420-2425.1998 Cheng, 2008, Effects of purification on the bioavailability of botulinum neurotoxin type A, Toxicology, 249, 123, 10.1016/j.tox.2008.04.018 DasGupta, 1977, Inhibition of Clostridium botulinum types A and B hemagglutinins by sugars, Can. J. Microbiol., 23, 1257, 10.1139/m77-188 Eisele, 2011, Studies on the dissociation of botulinum neurtoxin type A complexes, Toxicon, 57, 555, 10.1016/j.toxicon.2010.12.019 Fujinaga, 2010, Interaction of botulinum toxin with the epithelial barrier, J. Biomed. Biotechnol., 10.1155/2010/974943 Fujinaga, 2009, A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption, Toxicon, 54, 583, 10.1016/j.toxicon.2008.11.014 Hasegawa, 2007, A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms, J. Biol. Chem., 282, 24777, 10.1074/jbc.M703446200 Hill, 2007, Genetic diversity among Botulinum Neurotoxin-producing clostridial strains, J. Bacteriol., 189, 818, 10.1128/JB.01180-06 Hill, 2009, Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains, BMC Biol., 7, 66, 10.1186/1741-7007-7-66 Hines, 2005, Characterization of botulinum progenitor toxins by mass spectrometry, Appl. Environ. Microbiol., 71, 4478, 10.1128/AEM.71.8.4478-4486.2005 Inoue, 1996, Molecular composition of Clostridium botulinum type A progenitor toxins, Infect. Immun., 64, 1589, 10.1128/IAI.64.5.1589-1594.1996 Jin, 2009, Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins – differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C, Microbiology, 155, 35, 10.1099/mic.0.021246-0 Maksymowych, 1998, Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells, J.Biol. Chem., 273, 21950, 10.1074/jbc.273.34.21950 Maksymowych, 2004, Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells, J. Pharmacol. Exp. Ther., 310, 633, 10.1124/jpet.104.066845 Matsumura, 2008, The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption, Cell Microbiol., 10, 355 Nakamura, 2007, Binding properties of Clostridium botulinum type C progenitor toxin to mucins, Biochim. Biophys. Acta, 1770, 551, 10.1016/j.bbagen.2006.11.006 Niwa, 2007, Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium, FEMS Immunol. Med. Microbiol., 49, 346, 10.1111/j.1574-695X.2006.00205.x Ohishi, 1984, Oral toxicities of Clostridium botulinum type A and B toxins from different strains, Infect. Immun., 43, 487, 10.1128/IAI.43.2.487-490.1984 Ohishi, 1977, Oral toxicities of Clostridium botulinum toxins in response to molecular size, Infect. Immun., 16, 107, 10.1128/IAI.16.1.107-109.1977 Rasetti-Escargueil, 2009, Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice, Toxicon, 53, 503, 10.1016/j.toxicon.2009.01.019 Reed, 1938, A simple method of estimating fifty per cent endpoints, Am. J. Hyg., 27, 493 Scarlatos, 2005, Methods for detecting botulinum toxin with applicability to screening foods against biological terrorist attacks, J. Food Sci., 70, 121, 10.1111/j.1365-2621.2005.tb11525.x Simpson, 2004, Identification of the major steps in botulinum toxin action, Annu. Rev. Pharmacol. Toxicol., 44, 167, 10.1146/annurev.pharmtox.44.101802.121554 Smith, 2007, Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids, PLoS One, 2, e1271, 10.1371/journal.pone.0001271 Sugii, 1977, Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes, Infect. Immun., 16, 910, 10.1128/IAI.16.3.910-914.1977 Weil, 1952, Tables for the convenient calculation of median-effective dose (LD50 or ED50) and instructions in their use, Biometrics, 8, 249, 10.2307/3001557 Zhou, 2005, Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II, FEBS J., 272, 2717, 10.1111/j.1742-4658.2005.04688.x